Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

227 ARTÍCULOS , VIENDO DEL 61 AL 75

Strength: a relevant link to functional performance in the neurodegenerative disease of adrenomyeloneuropathy

Keller JL, Wang JI, Kang JY, Hanson JA, Kamath P, Swain JO, Raymond GV, Zackowski KM.

Neurorehabil Neural Repair. 2012 Nov-Dec;26(9):1080-8. doi: 10.1177/1545968312441682. Epub 2012 Apr 27.

Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance

Finsterer J, Löscher W, Quasthoff S, Wanschitz J, Auer-Grumbach M, Stevanin G.

J Neurol Sci. 2012 Jul 15;318(1-2):1-18. doi: 10.1016/j.jns.2012.03.025. Epub 2012 May 1.

Ultrasonographic measurement of the femoral cartilage thickness in hemiparetic patients after stroke

Tunç H, Oken O, Kara M, Tiftik T, Doğu B, Unlü Z, Ozçakar L.

Int J Rehabil Res. 2012 Sep;35(3):203-7. doi: 10.1097/MRR.0b013e3283532736.

Spasticity following spinal cord injury

Rekand T, Hagen EM, Grønning M.

Tidsskr Nor Laegeforen. 2012 Apr 30;132(8):970-3. doi: 10.4045/tidsskr.10.0872.

Severity score system for progressive myelopathy: development and validation of a new clinical scale

Castilhos RM, Blank D, Netto CB, Souza CF, Fernandes LN, Schwartz IV, Giugliani R, Jardim LB.

Braz J Med Biol Res. 2012 Jul;45(7):565-72. doi: 10.1590/s0100-879x2012007500072. Epub 2012 May 10.

[Cannabinoid drugs for neurological diseases: what is behind?]

Fernández-Ruiz J.

Rev Neurol. 2012 May 16;54(10):613-28.

Potential control of multiple sclerosis by cannabis and the endocannabinoid system

Pryce G, Baker D.

CNS Neurol Disord Drug Targets. 2012 Aug;11(5):624-41. doi: 10.2174/187152712801661310.

Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B.

CMAJ. 2012 Jul 10;184(10):1143-50. doi: 10.1503/cmaj.110837. Epub 2012 May 14.

Static balance and function in children with cerebral palsy submitted to neuromuscular block and neuromuscular electrical stimulation: study protocol for prospective, randomized, controlled trial

Kazon S, Grecco LA, Pasini H, Corrêa JC, Christovão TC, de Carvalho Pde T, Giannasi LC, Lucareli PR, de Oliveira LV, Salgado AS, Sampaio LM, Oliveira CS.

BMC Pediatr. 2012 May 16;12:53. doi: 10.1186/1471-2431-12-53.

Management of spasticity in progressive multiple sclerosis: efficacy of repeated intrathecal triamcinolone acetonide administration

Abu-Mugheisib M, Benecke R, Zettl UK.

Curr Pharm Des. 2012;18(29):4564-9. doi: 10.2174/138161212802502251.

Microcephaly-thin corpus callosum syndrome maps to 8q23.2-q24.12

Halevy A, Basel-Vanagaite L, Shuper A, Helman S, Har-Zahav A, Birk E, Maya I, Kornreich L, Inbar D, Nürnberg G, Nürnberg P, Steinberg T, Straussberg R.

Pediatr Neurol. 2012 Jun;46(6):363-8. doi: 10.1016/j.pediatrneurol.2012.03.014.

The effect of supported standing in adults with upper motor neurone disorders: a systematic review

Newman M, Barker K.

Clin Rehabil. 2012 Dec;26(12):1059-77. doi: 10.1177/0269215512443373. Epub 2012 May 29.

Virtual electric power wheelchair driving performance of individuals with spastic cerebral palsy

Dicianno BE, Mahajan H, Guirand AS, Cooper RA.

Am J Phys Med Rehabil. 2012 Oct;91(10):823-30. doi: 10.1097/PHM.0b013e31825a1497.

Neurorehabilitation with versus without resistance training after botulinum toxin treatment in children with cerebral palsy: a randomized pilot study

Bandholm T, Jensen BR, Nielsen LM, Rasmussen H, Bencke J, Curtis D, Pedersen SA, Sonne-Holm S.

NeuroRehabilitation. 2012;30(4):277-86. doi: 10.3233/NRE-2012-0756.

Sativex® in multiple sclerosis spasticity: a cost-effectiveness model

Slof J, Gras A.

Expert Rev Pharmacoecon Outcomes Res. 2012 Aug;12(4):439-41. doi: 10.1586/erp.12.40. Epub 2012 Jun 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias